关于大气阻塞对伊斯坦布尔空气质量影响的多来源观察:一个研究案例
Emrah Tuncay Özdemir1, Enes Birinci2, Ali Deniz1
1Department of Meteorological Engineering, İstanbul Technical University, 34469, Maslak, Istanbul, Turkey.
Environmental monitoring and assessment
|July 4, 2024
概括
大气阻塞导致2022年12月30日至2023年1月5日伊斯坦布尔的严重空气污染. 颗粒物 (PM10和PM2.5) 水平升,导致空气质量差,而臭氧水平没有受到影响.
科学领域:
- 大气科学 大气科学
- 环境科学 环境科学
- 空气质量监测 空气质量监测
背景情况:
- 大气动力学显著影响空气污染水平.
- 之前的研究表明,气象条件和污染物度之间存在相关性.
研究的目的:
- 调查大气阻塞对伊斯坦布尔空气污染的影响.
- 在特定的阻塞事件中量化颗粒物度的增加.
主要方法:
- 利用来自16个空气质量监测站的每小时污染物数据.
- 从 ERA5 数据库中提取了用于气象和天气分析的重新分析数据.
- 采用天花板计数据来计算云高度和垂直可见度,并使用R和Grads进行统计分析.
主要成果:
- 2022年12月30日至2023年1月5日的一次欧米茄型阻塞事件导致PM10和PM2.5度的峰值分别为572.8和254.20μg/m3.
- 活动期间的平均污染物度超过了典型的1月至2月的平均值,这表明空气质量差.
- 臭氧度没有受到显著影响,但由于阻断效应,颗粒物水平大幅增加.
结论:
- 大气阻塞在2022年12月30日至2023年1月5日期间显著降低了伊斯坦布尔的空气质量.
- 该研究强调了大气动态在加剧空气污染事件中的关键作用.
- 活动期间观察到云高度降低和垂直可见性降低,与严重的空气污染条件一致.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
234
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
234
Drugs Used in Lower Respiratory Disorders: Overview
397
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
397
Factors Affecting Pulmonary Ventilation
1.3K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
1.3K
Antiasthma Drugs: Muscarinic Receptor Antagonists
280
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
280


